网状Meta分析优先报告规范简介和案例解读

网状Meta分析优先报告规范简介和案例解读

田金徽,葛龙,赵晔,张珺,苏小杰,刘爱萍,张俊华

兰州大学循证医学中心，兰州大学基础医学院,兰州大学循证医学中心，兰州大学基础医学院,兰州大学循证医学中心，兰州大学基础医学院,甘肃中医药大学护理学院,兰州大学循证医学中心，兰州大学基础医学院,甘肃卫生职业学院,天津中医药大学循证医学中心

收稿日期:2015-10-08 修回日期:2015-10-08 出版日期:2015-10-25 发布日期:2015-10-25
基金资助:
]甘肃省循证医学与临床转化重点实验室开放基金；2015年兰州大学中央高校基本科研业务专项资金资助(编号：lzujbky-2015-233)

An introduction to PRISMA extension statement for network meta-analysis

Evidence-based Medicine Center,School of Basic Medical Sciences,Lanzhou University,Gansu Lanzhou,Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University,Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou

Received:2015-10-08 Revised:2015-10-08 Online:2015-10-25 Published:2015-10-25

摘要/Abstract

摘要： 网状Meta分析(Network Meta-Analysis, NMA)作为循证医学发展的二代方法学,越来越受到各国卫生技术评估组织的认可,然而目前NMA的报告存在严重的问题。最近针对NMA的优先报告规范——PRISMA扩展申明被发表在Annals of Internal Medicine上,本文将PRISMA扩展申明介绍给国内学者,为国内研究人员撰写和报告高质量的NMA提供借鉴和参考。

田金徽,葛龙,赵晔,张珺,苏小杰,刘爱萍,张俊华. 网状Meta分析优先报告规范简介和案例解读[J]. .

参考文献

[1]姚亮,陈耀龙,王琪,等. 病例报告的报告规范解读[J]. 中国循证儿科杂志,2014,9(3):216-219.
[2]Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement[J]. The Lancet, 1999, 354(9193): 1896-1900.
[3]Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement[J]. Ann Intern Med, 2009,151:264-269.
[4]Moher D, Liberati A, Tetzlaff J, 等. 系统综述和荟萃分析优先报告的条目: PRISMA 声明[J]. 中西医结合学报, 2009, 7(9): 889-896.
[5]周为文,葛龙,徐俊峰,等. 《中国循证医学杂志》发表的干预类系统评价/Meta分析报告质量评价[J].中国循证医学杂志,2013,13(4):482-488.
[6]葛龙,李雅睿,曾巧铃,等. 发表于《中华儿科杂志》的系统评价/Meta分析的报告质量和方法学质量评价[J].中华医学图书情报杂志,2013,22(12):55-60.
[7]Panic N, Leoncini E, de Belvis G, et al. Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses[J]. PLoS One. 2013;8: e83138.
[8]Li JL,Ge L, Ma JC et al.Quality of reporting of systematic reviews published in "evidence-based" Chinese journals.Syst Rev, 2014,3:58.
[9]李伦,田金徽,杨克虎.网状Meta分析的报告规范现状分析[J].中国循证儿科杂志,2014,9(6):467-471.
[10]Hutton B,Salanti G,Caldwell DM, et al. The PRISMASExtension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions:Checklist and Explanations[J]. Ann Intern Med,2015,162(11):777-784.
[11]李伦,杨克虎,田金徽. 网状Meta分析相关术语和定义的研究[J]. 中国药物评价,2014,31(6):321-326.
[12]Kirkham JJ, Altman DG, Williamson PR. Bias due to changes in specified outcomes during the systematic review process[J]. PLoS ONE, 2010,5(3):e9810.
[13]Kirkham JJ, Dwan KM, Altman DG, et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews[J]. BMJ, 2010, 340:c365.
[14]Page MJ, McKenzie JE, Kirkham J, et al. Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions [J]. Cochrane Lib, 2014, (10):Art No.:MR000035.
[15]Thorlund K, Druyts E, Avi?a-Zubieta JA, et al. Why the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomings[J]. Annals of the rheumatic diseases, 2013, 72(9): 1524-1535.
[16]葛龙,安妮,曾巧铃,等. 我国干预类系统评价/Meta分析文献检索新挑战[J]. 中华医学图书情报杂志,2013,22(5):2-8.
[17]梁莉,葛龙,周为文,等. 我国诊断性试验系统评价/Meta分析的检索情况调查分析[J]. 中华医学图书情报杂志,2013,22(5):9-16.
[18]Li L, Tian J, Tian H, et al. Network meta-analyses could be improved by searching more sources and by involving a librarian[J]. J Clin Epidemiol, 2014, 67(9): 1001-1007.
[19]Jansen JP,Naci H. Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers[J].BMC Med,2013,11:159.
[20]Lathyris DN, Patsopoulos NA, Salanti G, et al. Industry sponsorship and selection of comparators in randomized clinical trials[J]. Eur J Clin Invest, 2010,40:172-182.
[21]Mills EJ,Kanters S,Thorlund K, et al. The effects of excluding treatments from network meta-analyses: survey[J].BMJ,2013,347:f5195.
[22]Higgins JP,SAltman DG,SG?tzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials[J]. BMJ, 2011,343:d5928.
[23]Eckermann S, Coory M, Willan AR. Indirect comparison: relative risk fallacies and odds solution[J]. J Clin Epidemiol, 2009, 62(10): 1031-1036.
[24]张超,鄢金柱,孙凤,等.网状Meta分析一致性的鉴别与处理方法[J]. 中国循证医学杂志,2014,14(7):884-888.
[25] Chaimani A, Higgins JP, Mavridis D, et al. Graphical tools for network meta-analysis in STATA[J]. PLoS One, 2013,8:e76654.
[26]王小琴,韦当,刘雅莉,等.PRISMA声明应用现状调查[J]. 中国循证医学杂志,2014,14(9):1160-1164.
[27]Moher D, Shamseer L, Clarke M, et al.Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement[J].Syst Rev, 2015,4:1.
[28]Stewart LA, Clarke M, Rovers M, et al.Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: theSPRISMA-IPDSStatement[J].JAMA, 2015 313(16):1657-1665.